Net profit of Piramal Pharma declined 63.60% to Rs 3.68 crore in the quarter ended December 2024 as against Rs 10.11 crore during the previous quarter ended December 2023. Sales rose 12.54% to Rs 2204.22 crore in the quarter ended December 2024 as against Rs 1958.57 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 2204.22 | 1958.57 | 13 |
| OPM % | 15.32 | 13.70 | - |
| PBDT | 263.61 | 237.95 | 11 |
| PBT | 66.80 | 51.63 | 29 |
| NP | 3.68 | 10.11 | -64 |